Palisade Capital Management LP Buys New Shares in Acadia Healthcare Company, Inc. $ACHC

Palisade Capital Management LP bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 456,960 shares of the company’s stock, valued at approximately $13,494,000. Palisade Capital Management LP owned approximately 0.49% of Acadia Healthcare as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ACHC. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Federated Hermes Inc. raised its stake in Acadia Healthcare by 1.5% during the 4th quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Acadia Healthcare by 0.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after acquiring an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio grew its stake in Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after acquiring an additional 867 shares during the period. Finally, Treasurer of the State of North Carolina increased its holdings in shares of Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares in the last quarter.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a research report on Monday, May 4th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Barclays increased their price objective on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Finally, Guggenheim upped their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Stock Up 4.0%

Acadia Healthcare stock opened at $29.87 on Wednesday. The firm has a 50 day simple moving average of $30.14 and a 200 day simple moving average of $25.81. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83. The firm has a market capitalization of $2.78 billion, a price-to-earnings ratio of -2.40, a P/E/G ratio of 9.25 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same quarter in the prior year, the business posted $0.83 earnings per share. The business’s quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.